Investigations in human cohorts have demonstrated that loss-of-function mutations in HSD17B13 gene confer protection against liver inflammation and fibrosis, paradoxically correlating with enhanced lipid deposition (Abul-Husn et al, 2018; Luukkonen et al, 2020; Ma et al, 2019). The gene discussed is HSD17B13; the disease is inflammatory response.